Skip to main content

Prevalence of metabolic syndrome among ethnic groups in China

Abstract

Background

Metabolic syndrome (MetS) is common in China, which has a multi-ethnic population of 1·3 billion. We set out to determine the prevalence of MetS and its components in different ethnic groups.

Methods

This nationwide cross-sectional survey involved 24,796 participants from eight ethnicities in six provinces in China from 2008 to 2011. MetS was defined using the modified National Cholesterol Education Program Adult Treatment Panel III criteria. Results were analysed using SPSS version 22·0 in 2018. Logistic regression was used for deriving odds ratios and 95% confidence intervals of risk factors for the MetS.

Results

The prevalence of MetS increased with age from 3·60% to 21·68%. After age standardization, the prevalence of MetS, in descending order, was 35·42% (Korean), 22·82% (Hui), 19·80% (Han), 13·72% (Miao), 12·90% (Tujia), 12·04% (Li), 11·61% (Mongolian), 6·17% (Tibetan). Korean ethnicity was associated with a higher prevalence in five components of MetS, while Tibetan ethnicity was associated with lower prevalence except decreased HDL cholesterol. Logistic regression analyses showed that age, drinking and being non-Tibetan were associated with a higher risk of MetS.

Conclusions

Within one country, albeit a large one, the prevalence of MetS can vary greatly. Chinese of Korean ethnicity had a much higher prevalence than Tibetan ethnicity. Measures to tackle MetS should be tailored to the ethnic groups within a population.

Peer Review reports

Background

Metabolic Syndrome (MetS) is a cluster of related abnormalities that include abdominal obesity, insulin resistance, dyslipidaemia and elevated blood pressure [1, 2]. The National Cholesterol Education Program’s Adult Treatment Panel III (NCEP: ATPIII), World Health Organization (WHO) and International Diabetes Federation (IDF) use this syndrome to highlight the risk of patients developing cardiovascular disease (CVD) and type 2 diabetes (T2DM) [1, 3]. We previously reported that the prevalence of MetS in the United States was 33·6% in the adult population [4]. MetS predicts the development of diabetes [5] and hypertension [6], and is also associated with coronary artery disease (CAD) [7] and increased mortality [8].

While the natural history of MetS and how it develops have been well described in Hong Kong Chinese, a large number of observational studies have also been conducted in China, the population of which is mostly of Han ethnicity [9, 10]. A meta-analysis showed that the pooled prevalence of MetS in China was 24·5% among subjects aged over 15 years. Individuals living in urban areas had a higher risk of having MetS than those living in rural areas [11]. However, China is a multi-ethnic country with at least 55 ethnic groups. There are few studies focused on MetS among different ethnic groups in China, and most of these studies focused on a single ethnic group [7, 12, 13]. The heterogeneity in study design, inclusion criteria and definition of MetS makes it difficult to compare the prevalence in different ethnic groups.

Building on the Expansion Investigation of Human Physiology Constant Study in China [14], we made use of unified inclusion criteria and centralized measurements to determine the prevalence of Metabolic Syndrome (MetS) among different ethnicities in six provinces of China using the modified NCEP: ATPIII criteria [15].

Methods

Description of the study

The Expansion Investigation of Human Physiology Constant was a nationwide cross-sectional, random and multistage clustering sampled survey in China that is part of the National Constitution and Health Database in 2008–2011 [16]. Our previous studies based on the National Constitution and Health Database had shown several factors associated with cardiovascular disease [14, 17]. This study was expanded to six provinces and eight ethnic groups according to the geographical, ethnical and economic characteristics from the previous studies. All study personnel was trained with standardised working manuals and surveys before they conducted this study. Sample processing, testing and quality control were conducted by certified personnel in a central laboratory (Department of Laboratory Medicine in Peking Union Medical College Hospital) to ensure the consistency and stability of the measurements.

Subjects

Participants aged 8–86 years were recruited from six provinces (Inner Mongolian, Heilongjiang, Ningxia, Hunan, Yunnan, Sichuan) using a random, multistage cluster-sampling method as shown in Fig. 1. Eight ethnic groups, including Han, Mongolian, Korean, Hui, Miao, Li, Tibetan and Tujia, were enrolled in this study. Inclusion criteria were absence of self-reported systemic diseases, such as CAD, renal disease, autoimmune disease, hypersensitivity, gastrointestinal disease, pulmonary disease, and cancer. Considering different customs of ethnic groups, we included participants aged 8–86. Exclusion criteria included significant abnormalities on physical examination, and having a fever, acute illness, or hospitalization within 15 days. This study was approved by the Ethics Committee of Institute of Basic Medical Sciences Chinese Academy of Medical Sciences (No·005–2008). Written consents were obtained from all participants.

Fig. 1
figure1

Distributions of participants in China

Data collection

Participants were required to complete a demographic questionnaire and a health behaviour questionnaire, which included smoking, alcohol consumption and physical activity. Trained personnel assisted the participants in completing the questionnaires.

Measurements

All participants were asked to avoid smoking and heavy physical activity for at least 2 h before the physical examinations, which included resting blood pressure, height, weight, and waist circumference (WC). Two blood pressure measurements were taken using OMRON HEM-7000 electronic sphygmomanometer (OMRON HealthCare, Kyoto, Japan) after the participants had rested in a sitting position for at least 5 min.

Participants were required to fast for 8 to 12 h before blood sampling. Fasting blood glucose (GLU), total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL cholesterol), and low-density lipoprotein cholesterol (LDL cholesterol) were analysed using a Hitachi 7020 chemistry analyser (Hitachi, Tokyo, Japan). Body mass index (BMI) was a person’s weight in kilograms divided by the square of height in meters.

Definition of metabolic syndrome

The modified ATP III criteria were applied in the diagnosis of MetS, which requires the presence of at least three out of five factors [15]: (i) Abdominal density as defined by waist circumference ≥ 90 cm in men and ≥ 80 cm in women; (ii) triglycerides ≥1·7 mmol/L; (iii) HDL cholesterol < 1·03 mmol/L in men and < 1·29 mmol/L in women; (iv) systolic blood pressure (SBP) ≥130 mmHg or diastolic blood pressure (DBP) ≥ 85 mmHg; (v) GLU ≥5·6 mmol/L as impaired fasting glucose (IFG).

Statistical analysis

Results were analysed using SPSS version 22·0 (IBM SPSS Statistics, Armonk, NY, USA) in 2018. Descriptive statistics were expressed as frequency (percentage) for categorical data or mean ± SD or median (interquartile range) for continuous variables. Missing data were less than 3% for all included variables. Continuous variables were compared among groups using one-way ANOVA and Kruskal-Wallis tests as appropriate. Categorical variables were compared among groups using Chi-square test. Logistic regression was used to identify the predictors for MetS. Gender, age, ethnicities, exercises, smoking status, drinking status were included in the model. Age groups and gender were entered into the first adjusted model. Other predictor variables were entered stepwise if P < 0·05 and removed if P > 0·10. Exercise was added as a covariate in the second adjusted model and ethnicities, drinking status, smoking status were applied in the third adjusted model. Odds ratios (ORs) and 95% confidential interval (95% CI) were estimated. A two-tailed P < 0·05 was considered statistically significant. Data from the Sixth National Population Census of the People’s Republic of China provided by the National Statistics Bureau of China were used as the standard population. Age-specific prevalence and age-standardized prevalence were estimated from the standard population.

Results

A total of 24,796 participants were enrolled in this study (Fig. 2). The characteristics are summarized in Supplementary Table 1. There was a significant difference in the median age among participants from different provinces and ethnic groups (shown in Supplementary Table 1, 2 and 3). Compared with Hans in the same province, participants from Tibetan, Miao, Tujia, Mongolian, Li ethnic groups were younger (P < 0·001).

Fig. 2
figure2

A flow diagram for inclusion of study samples

The prevalence of MetS in eight ethnic groups of China

The age, gender and ethnic-specific crude and standardised prevalence of MetS are summarised in Table 1. The prevalence of MetS in males (13·5%) was slightly higher than in females (12·6%) (P = 0·28). The prevalence of MetS was substantially higher above age 25 (24·7%) compared with age ≤ 25 (2·3%) (P < 0·001). There was a significant difference in MetS prevalence among ethnic groups (P < 0·001). Korean Chinese had the highest prevalence of 35·42, followed by Hui, Han, Miao, Tujia, Li, Mongolian and Tibetan (Table 1, Fig. 3).

Table 1 The prevalence of MetS stratified by age, gender and eight ethnic groups in China
Fig. 3
figure3

Standardized Prevalence of MetS in ethnic groups in China stratified by gender

The prevalence of MetS components

Figure 4 shows the prevalence of components of MetS in different ethnic groups. The highest prevalence of abdominal obesity, hyperlipidaemia, decreased HDL cholesterol, elevated blood pressure and IFG were found in Han, Li, Hui, Li and Korean ethnicities, respectively; while the lowest prevalence of the components of MetS appeared in Li and Tibetan ethnicities (Fig. 4). In all ethnic groups, the prevalence of decreased HDL cholesterol and elevated blood pressure were the two highest among the five components, while IFG was less prevalent, especially in Miao, Mongolian, Tibetan, Hui and Tujia ethnicities.

Fig. 4
figure4

The prevalence of MetS components in ethnic groups in China

Predictors for MetS

Predictors for MetS are summarized in Table 2. Age, gender, smoking, alcohol consumption and ethnic groups were all significant risk factors for MetS in the crude model (p < 0·001, p = 0·027, p < 0·001, p < 0·001, p < 0·001, respectively). Compared to females, males had an increased risk of MetS [OR (95% CI): 1·087 (1·009–1·171), p = 0·027]. However, maleness [1·028 (0·930–1·137), p = 0·059] and smoking [0·908 (0·806–1·022), p = 0·110] were not significant factors for MetS after multivariable adjustment. Compared to participants aged 8 to 12 years, the OR increased with age, and was highest in participants aged 60 to 86 years [34·117 (24·673–47·177), p < 0·001]. Relative to Tibetans, all other ethnicities were associated with increased risk of MetS. Korean Chinese had the highest adjusted risk for MetS [5·989 (4·249–8·442), p < 0.001], followed by Hui [4·020 (2·859–5·653), p < 0.001], Han [2·975 (2·194–4·034), p < 0.001], Li [2·096 (1·487–2·954), p < 0·001], Miao [1·961 (1·262–3·048), p = 0·003], Mongolian [1·835 (1·272–2·648), p = 0·001] and Tujia [1·753 (1·166–2·637), p = 0·007] ethnicities. MetS was not significantly associated with exercise in both crude and adjusted models (P = 0·140, P = 0·710, P = 0·710, P = 0·905, respectively).

Table 2 Predictors of metabolic syndrome

Discussion

This study is the first large-scale multi-ethnic investigation of the prevalence of MetS in China. With 24,796 participants, it had sufficient power to estimate and compare prevalence in subgroups. Such comparisons are also valid and reliable because we had standardised protocols, rigorous quality control and a central clinical laboratory for measurements. The large sample size, standardised measurements and the quality control allowed us to have accurate estimates of the prevalence of MetS in the general population in China. It is a strength of the study to recruit from the age of 8 to 86, which is an uncommonly wide range for an epidemiological study. The study did not recruit subjects below the age of 8 or above the age of 86 for practical reasons.

The prevalence of MetS in Hans in the present study was higher than a previous national study in China [18], but lower or similar to the prevalence in US and Europe [19, 20]. Due to economic development, consumption of dairy products and fast foods had doubled [21, 22], which might have contributed to the increasing trend in MetS. The prevalence of MetS was slightly higher in men in this study, in contrast to some other populations [23].

The prevalence of MetS in Korean, Hui and Mongolian Chinese in our study is relatively higher than previous studies’ in these ethnicities [24,25,26]. A study using the Korean National Health and Nutrition Examination Survey (KNHANES) data from 2008 to 2013 reported that the prevalence of MetS among the Korean participants aged ≥20 years was 28·9% according to the modified NCEP: ATPIII definition [25]. A study conducted among rural adults in Ningxia in 2008 reported that the age-adjusted prevalence of MetS was 13·7% with International Diabetes Federation definition [26]. In Mongolians aged over 18 years, the prevalence of MetS in men was higher than in women (36·7% vs. 17·8%) [24]. However, a study of Tibetan immigrants in India aged over 20 years reported a prevalence of 10·6% in men and 33·3% in women [27]. In our study, Tibetans had a much lower prevalence of MetS as a result of possible volunteer bias.

This study revealed that the prevalence of the components of MetS varied greatly in different ethnicities. These differences may be due to genetic factors and environmental factors, which include diet and lifestyle. A randomized dietary and behavioural interventional study showed that a Tibetan diet reduced body weight and BMI in patients with CAD and MetS [28]. This might be the reason why Tibetans in our study had a low prevalence of MetS. The increased prevalence of MetS in Korean ethnicity might also be explained by diet, since it has been shown that dietary intakes of total fat and saturated fatty acids were significantly associated with MetS [29].

The association of gender with MetS is controversial [30,31,32]. In this study, the association of maleness with MetS was weak and became not significant in the multivariable model. In previous studies, it have been shown that advanced age and drinking status were both associated with higher risk of MetS, while the association with exercise and smoking status was equivocal [33,34,35]. Our finding that Chinese of Korean and Tibetan ethnicities had the highest and lowest prevalence for MetS respectively should prompt further studies to explore the possible causes of ethnic difference in the risk of developing MetS. Such studies should include a detailed dietary and lifestyle survey, and a study of socioeconomic and genetic factors.

Limitations

There were some limitations in this study. China is a large country, so 24,796 participants represent only a small fraction of the total population. We were unable to study minorities in very remote parts of China. Different ethnic groups have different religious beliefs and customs, and these may account for some of the differences.

Conclusions

In this large multi-ethnic population-based survey, the age-standardized prevalence of MetS varied greatly in different ethnic groups, ranging from 6·18% to 35·43%. Korean ethnicity was associated with a higher prevalence of MetS and its components, while Tibetan ethnicity was associated with a lower prevalence of MetS and its components except decreased HDL cholesterol.

Availability of data and materials

The datasets used and/or analysed during the current study are available on reasonable request.

Abbreviations

BMI:

Body mass index

CAD:

Coronary artery disease

CVD:

Cardiovascular disease

DBP:

Diastolic blood pressure

GLU:

Fasting blood glucose

HDL cholesterol:

High-density lipoprotein cholesterol

IDF:

World Health Organization (WHO) and International Diabetes Federation

IFG:

Impaired fasting glucose

KNHANES:

Korean National Health and Nutrition Examination Survey

LDL cholesterol:

Low-density lipoprotein cholesterol

MetS:

Metabolic syndrome

NCEP: ATPIII:

The National Cholesterol Education Program’s Adult Treatment Panel III

ORs, 95% CI:

Odds ratios and 95% confidential interval

SBP:

Systolic blood pressure

T2DM:

Type 2 diabetes

WC:

Waist circumference

References

  1. 1.

    Alberti KGMM, et al. The metabolic syndrome: a new worldwide definition. Lancet. 2005;366(9491):1059–62.

    Article  Google Scholar 

  2. 2.

    Cheung BM, Thomas GN. The metabolic syndrome and vascular disease in Asia. Cardiovasc Hematol Disord Drug Targets. 2007;7(2):79–85.

    CAS  Article  Google Scholar 

  3. 3.

    Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–97.

    Article  Google Scholar 

  4. 4.

    Cheung BM, et al. Prevalence of the metabolic syndrome in the United States National Health and nutrition examination survey 1999-2002 according to different defining criteria. J Clin Hypertens (Greenwich). 2006;8(8):562–70.

    Article  Google Scholar 

  5. 5.

    Cheung BM, et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care. 2007;30(6):1430–6.

    Article  Google Scholar 

  6. 6.

    Cheung BM, et al. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong cardiovascular risk factor prevalence Study-2 (CRISPS2). Am J Hypertens. 2008;21(1):17–22.

    CAS  Article  Google Scholar 

  7. 7.

    Gui MH, et al. Effect of metabolic syndrome score, metabolic syndrome, and its individual components on the prevalence and severity of angiographic coronary artery disease. Chin Med J. 2017;130(6):669–77.

    Article  Google Scholar 

  8. 8.

    Cheung BM, et al. Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese. Clin Endocrinol. 2008;68(5):730–7.

    CAS  Article  Google Scholar 

  9. 9.

    Gu D, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005;365(9468):1398–405.

    Article  Google Scholar 

  10. 10.

    Yang G. Salt intake in individuals with metabolic syndrome. Lancet. 2009;373(9666):792–4.

    Article  Google Scholar 

  11. 11.

    Li R, et al. Prevalence of metabolic syndrome in mainland China: a meta-analysis of published studies. BMC Public Health. 2016;16(1):296.

    Article  Google Scholar 

  12. 12.

    He J, et al. The optimal ethnic-specific waist-circumference cut-off points of metabolic syndrome among low-income rural Uyghur adults in far Western China and implications in preventive public health. Int J Environ Res Public Health. 2017;14(2):158.

    Article  Google Scholar 

  13. 13.

    Yan YZ, et al. Association of Insulin Resistance with glucose and lipid metabolism: ethnic heterogeneity in far Western China. Mediat Inflamm. 2016;2016:1–8.

    CAS  Google Scholar 

  14. 14.

    Qin X, et al. Association between gamma-glutamyltransferase and prehypertension. Mol Med Rep. 2012;5(4):1092–8.

    CAS  Article  Google Scholar 

  15. 15.

    Grundy SM, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–52.

    Article  Google Scholar 

  16. 16.

    Xu T, Zhu GJ, Han SM. Study of zero-inflated regression models in a large-scale population survey of sub-health status and its influencing factors. Chin Med Sci J. 2017;32(4):218–25.

    Article  Google Scholar 

  17. 17.

    Wu J, et al. Prevalence and clustering of major cardiovascular risk factors in China: a recent cross-sectional survey. Medicine (Baltimore). 2016;95(10):e2712.

    Article  Google Scholar 

  18. 18.

    He Y, et al. Prevalence of metabolic syndrome and individual metabolic abnormalities in China, 2002-2012. Asia Pac J Clin Nutr. 2019;28(3):621–33.

    PubMed  Google Scholar 

  19. 19.

    Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and nutrition examination survey, 1988–2012. Prev Chronic Dis. 2017;14:160287.

    Article  Google Scholar 

  20. 20.

    Agyemang C, et al. A cross-national comparative study of metabolic syndrome among non-diabetic Dutch and English ethnic groups. Eur J Pub Health. 2013;23(3):447–52.

    Article  Google Scholar 

  21. 21.

    Xue H, et al. Time trends in fast food consumption and its association with obesity among children in China. PLoS One. 2016;11(3):e0151141.

    Article  Google Scholar 

  22. 22.

    Zhao Y, et al. Fast food consumption and its associations with obesity and hypertension among children: results from the baseline data of the childhood obesity study in China mega-cities. BMC Public Health. 2017;17(1):933.

    Article  Google Scholar 

  23. 23.

    Pucci G, et al. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature. Pharmacol Res. 2017;120:34–42.

    Article  Google Scholar 

  24. 24.

    You L, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area. J Atheroscler Thromb. 2014;21(4):355–65.

    Article  Google Scholar 

  25. 25.

    Tran BT, Jeong BY, Oh JK. The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults: results from the Korean National Health and nutrition examination survey 2008-2013. BMC Public Health. 2017;17(1):71.

    Article  Google Scholar 

  26. 26.

    Zhao Y, et al. Prevalence of the metabolic syndrome among rural original adults in NingXia, China. BMC Public Health. 2010;10(1):140.

    CAS  Article  Google Scholar 

  27. 27.

    Lin BY, et al. The prevalence of obesity and metabolic syndrome in Tibetan immigrants living in high altitude areas in Ladakh, India. Obes Res Clin Pract. 2018;12(4):365–71.

    Article  Google Scholar 

  28. 28.

    von Haehling S, et al. Weight reduction in patients with coronary artery disease: comparison of traditional Tibetan medicine and Western diet. Int J Cardiol. 2013;168(2):1509–15.

    Article  Google Scholar 

  29. 29.

    Lee KW, et al. Association of dietary intakes of total and subtypes of fat substituted for carbohydrate with metabolic syndrome in Koreans. Endocr J. 2016;63(11):991–9.

    CAS  Article  Google Scholar 

  30. 30.

    Bentley-Lewis R, Koruda K, Seely EW. The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab. 2007;3(10):696–704.

    CAS  Article  Google Scholar 

  31. 31.

    Vryonidou A, et al. MECHANISMS IN ENDOCRINOLOGY: metabolic syndrome through the female life cycle. Eur J Endocrinol. 2015;173(5):R153–63.

    CAS  Article  Google Scholar 

  32. 32.

    Ong KL, et al. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension. 2008;51(4):1142–8.

    CAS  Article  Google Scholar 

  33. 33.

    Huang JH, et al. Lifestyle factors and metabolic syndrome among workers: the role of interactions between smoking and alcohol to nutrition and exercise. Int J Environ Res Public Health. 2015;12(12):15967–78.

    CAS  Article  Google Scholar 

  34. 34.

    Yu M, et al. Associations of cigarette smoking and alcohol consumption with metabolic syndrome in a male Chinese population: a cross-sectional study. J Epidemiol. 2014;24(5):361–9.

    Article  Google Scholar 

  35. 35.

    Kwasniewska M, et al. Smoking status, the menopausal transition, and metabolic syndrome in women. Menopause. 2012;19(2):194–201.

    Article  Google Scholar 

Download references

Acknowledgements

We acknowledge the assistance of the late Prof. James Miller from the University of Louisville in manuscript preparation. QXZ was the recipient of a Dr. Cheng Yu Tung Fellowship. We declare that the abstract of this manuscript has been presented at a research conference, the Lancet-CAMS Health Summit, 2019.

Funding

This study was supported by grants from the Special Fund for Key Basic Research Project of the Ministry of Science and Technology of P.R. China (No. 2006FY110 300). The funding authority does not have roles in this study.

Author information

Affiliations

Authors

Contributions

QXZ and TGD performed statistical analysis, interpreted the data and wrote the first draft. MFT, XT, ZL, QZH and BMYC contributed to data analysis and the writing of the final version of the manuscript. QL and ZGJ designed the study. All authors have approved the final version of the manuscript and its conclusions.

Corresponding author

Correspondence to Bernard M. Y. Cheung.

Ethics declarations

Ethics approval and consent to participate

We clarify the source of materials used in our study, and any permissions to collect such samples comply with institutional, national, or international guidelines. Written informed consent was obtained from participants or a parent or guardian for participants under 16 years old.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1: Table S1.

Characteristics of included participants stratified by ethnic groups. Table S2. Characteristics of included participants stratified by provinces. Table S3. Region, ethnicity and gender specific characteristics of participants stratified by provinces.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Qin, X., Qiu, L., Tang, G. et al. Prevalence of metabolic syndrome among ethnic groups in China. BMC Public Health 20, 297 (2020). https://doi.org/10.1186/s12889-020-8393-6

Download citation

Keywords

  • Metabolic syndrome
  • Ethnic group
  • China